Press release
Collaborations And Investments Drive Innovation In PTSD Therapeutics Market Industry Trends Gaining Momentum in the Global Post-Traumatic Stress Disorder Therapeutics Market
Post-Traumatic Stress Disorder Therapeutics
Post-Traumatic Stress Disorder Therapeutics Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for therapeutics focused on post-traumatic stress disorder has seen a consistent expansion in the past years. The growth is projected to increase from a valuation of $1.15 billion in 2024 to a size of $1.2 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.1%. The growth in the historic period can be linked to factors such as heightened awareness, an increase in trauma occurrence, government-led initiatives, advancements in diagnostic equipment, a decrease in stigma, psychological assistance programs, and an emphasis on veteran healthcare.
Post-Traumatic Stress Disorder Therapeutics Market Size Forecast: What's the Projected Valuation by 2029?
The market size for post-traumatic stress disorder therapeutics is projected to experience consistent development in the forthcoming years. It's anticipated to grow to "$1.36 billion by 2029 at a compound annual growth rate (CAGR) of 3.2%. Factors such as improved access to mental health services, government policies on mental health, and research in the biological and neurology sectors can account for this projected growth. The growth in non-military PTSD cases and crisis management planning also play a role. The period is likely to see significant trends such as the incorporation of digital therapeutics, advancements in drug treatments, techniques for brain and neurostimulation, therapy assisted by psychedelic substances, and joint research projects.
View the full report here:
https://www.thebusinessresearchcompany.com/report/post-traumatic-stress-disorder-therapeutics-global-market-report
What Are the Drivers Transforming the Post-Traumatic Stress Disorder Therapeutics Market?
The global escalation of post-traumatic stress disorder (PTSD) is anticipated to drive the advancement of the post-traumatic stress disorder therapeutics market. PTSD is a condition that manifests in individuals who have undergone horrifying, shocking, or perilous incidents. Treatments like psychotherapy and medication for PTSD can facilitate individuals to regain control over their lives. For example, data from the Ministry of Defence (MoD) Department of Community Mental Health (DCMH), a UK organization providing mental health services to personnel and reservists, showed that the number of armed forces personnel initially assessed for PTSD by a specialist mental health clinician rose from 266 cases in 2022 to 320 cases in 2023, according to a UK-based defense industry news website. This substantial increase in reported cases indicates that the growing burden of post-traumatic stress disorder (PTSD) incidents is fuelling the expansion of the post-traumatic stress disorder therapeutics market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9214&type=smp
What Are the Key Trends Driving Post-Traumatic Stress Disorder Therapeutics Market Growth?
A significant trend emerging in the post-traumatic stress disorder (PTSD) therapeutics market involves strategic partnerships, funding, and investments. This trend is being pursued by leading companies in the market as they seek to solidify their market positions. For example, in January 2022, over $1.9 million was allocated to a research team from Monash University, comprising Professor Dan Lubman AM, Dr. Shalini Arunogiri, and Dr. Paul Liknaitzky. The funding will enable them to investigate the effectiveness of MDMA-supported psychological treatment for alcohol use disorder and PTSD. This endeavor is part of seven clinical studies sponsored by the Medical Research Future Fund (MRFF), recently launched by the Federal government. These studies aim to explore potentially revolutionary combination medicines for the treatment of severe mental disorders.
Which Segments in the Post-Traumatic Stress Disorder Therapeutics Market Offer the Most Profit Potential?
The post-traumatic stress disorder therapeutics market covered in this report is segmented -
1) By Drug Class: Antidepressants, Anti-Anxiety, Antihypertensive, Monoamine Oxidase (MAOs), Antipsychotics Or Second Generation Antipsychotics (SGOs), Beta-Blockers, Other Classes
2) By Age Group: Pediatric, Geriatric, Adult
3) By End User: Mental Health Center, Hospitals, Outpatient Clinics, Other End Users
Subsegments:
1) By Antidepressants: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
2) By Anti-Anxiety: Benzodiazepines, Buspirone
3) By Antihypertensive: Prazosin, Clonidine
4) By Monoamine Oxidase Inhibitors (MAOs): Traditional MAOIs, Reversible MAOIs
5) By Antipsychotics (Second Generation Antipsychotics - SGOs): Risperidone, Quetiapine
6) By Beta-Blockers: Propranolol, Atenolol
7) By Other Classes: Mood Stabilizers, Adjunctive Therapies
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9214&type=smp
Which Firms Dominate the Post-Traumatic Stress Disorder Therapeutics Market by Market Share and Revenue in 2025?
Major companies operating in the post-traumatic stress disorder therapeutics market include Pfizer Inc., GlaxoSmithKline plc, Bionomics Limited, Otsuka Pharmaceutical Co Ltd., Eli Lilly and Company, AstraZeneca plc, Tonix Pharmaceuticals Holding Corp., Freespira Inc., MicroTransponder Inc., Compass Pathways plc, Boehringer Ingelheim International GmbH, Halucenex Life Sciences Inc., Bionorica SE, MAPS Europe BV, Hoffmann-La Roche Ltd., Praxis Precision Medicines Inc., H Lundbeck A/S, Johnson & Johnson, Sanofi SA, Takeda Pharmaceutical Company Limited, Merck KGaA, Jazz Pharmaceuticals plc
Which Regions Offer the Highest Growth Potential in the Post-Traumatic Stress Disorder Therapeutics Market?
North America was the largest region in the post-traumatic stress disorder therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-traumatic stress disorder therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9214
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Collaborations And Investments Drive Innovation In PTSD Therapeutics Market Industry Trends Gaining Momentum in the Global Post-Traumatic Stress Disorder Therapeutics Market here
News-ID: 4180562 • Views: …
More Releases from The Business Research Company
Emerging Trends to Reshape the Fill-Finish Pharmaceutical Contract Manufacturing …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Fill-Finish Pharmaceutical Contract Manufacturing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for fill-finish pharmaceutical contract manufacturing has seen robust growth in the past few years. The market, standing at $12 billion in 2024, is expected to expand to $13.03 billion in…
Dry Eye Syndrome Market Landscape to 2034: Key Forces Shaping the Next Decade of …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Dry Eye Syndrome Market Size By 2025?
The market size for dry eye syndrome has witnessed a robust growth in the last few years. Market size, which stands at $3.92 billion in 2024, will have an upward surge to $4.17 billion in 2025, with a…
The Surging Demand For Non-Therapeutic Biomolecules In Research And Laboratory T …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Non-Therapeutic Biomolecules Market Size By 2025?
The market share of non-therapeutic biomolecules has witnessed a swift expansion in the past few years. The market is estimated to advance from a valuation of $30.76 billion in 2024 to $33.92 billion in 2025, portraying a compound annual…
Soaring Demand Set to Propel Dermatology OTC Medications Market to $19.71 Billio …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Dermatology OTC Medications Market Through 2025?
In recent years, steady growth has been observed in the dermatology over-the-counter medications market. The market is estimated to expand from a size of $15.77 billion in 2024 to $16.23 billion in 2025, representing a compound…
More Releases for Stress
Leading Element Driving Change in the Stress Toy Market in 2025: Rising Stress A …
What Is the Estimated Market Size and Growth Rate for the Stress Toy Market?
In recent years, there has been a significant expansion in the stress toy market. The market, which was valued at $5.52 billion in 2024, is projected to increase to $5.88 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.6%. Several factors have contributed to growth during this historical period, including a higher incidence of…
Key Driver Reshaping the Stress Tracking Devices Market in 2025: Rising Stress-R …
"What Are the Projections for the Size and Growth Rate of the Stress Tracking Devices Market?
The market size for stress tracking devices has seen significant expansion in the past few years. Projected growth is from $3.14 billion in 2024 to $3.43 billion in 2025, with a Compound Annual Growth Rate (CAGR) of 9.3%. The key factors that have contributed to growth over the historical period include the upsurge in stress-related…
Stress Testing Solutions Market Exploring Opportunities in Macroprudential Stres …
Increase in demand for mobile applications with advanced features is expected to drive the stress testing solutions market considerably in next few years. In addition, factors such as rise in adoption of mobile devices, need to ensure systems can handle extreme workloads, and adoption of test automation services are expected to majorly drive growth of the market. However, data management & data quality issues and uncertainties about easy availability of…
Stress Management 2023
Globally, the COVID-19 pandemic affected not only the financial status but also the mental health of the individuals drastically which increased the stress management market to USD 18,700.9 million and expected to increase at a CAGR of 3.8% during the forecast period. Globally, 10% of the children encounter any least one of the mental disorders. The preliminary treatment could be discussing the issue with the cherished circle, whereas professional…
Agrow Plant Stress Products
ReportsWorldwide has announced the addition of a new report title Agrow Plant Stress Products 2016 to its growing collection of premium market research reports.
Abiotic stresses such as heat, cold and drought prevent crops from reaching their full potential productivity. Plant stress products are a new category, increasing the tolerance of crop plants to these and other adverse environments. They span conventional pesticides with ‘crop enhancement’ or ‘plant health’ promoting properties,…
National Stress Awareness Day
National Stress Awareness Day is on Wednesday 5th November 2014. Relaxa is offering employee stress & wellbeing health promotion packages starting at £255 on or around this date - incorporating a range of stress & wellbeing activities for your staff.
There are 9 cost-effective stress and wellbeing promotion packages available below:
1) Stress Health Promotion Package 1 - £255.00+vat
2) Stress Health Promotion Package 2 - £399.00+vat
3) Stress Health Promotion Package 3…
